Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Relapsed/Refractory Multiple Myeloma
NCT00047203Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2002
- Primary completion
- Sep 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in multiple myeloma (MM), sponsored by National Cancer Institute. Started Sep 2002; status: completed.
02
Drugs
alvocidib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00047203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047203.